FORM S-8
Table of Contents

As filed with the Securities and Exchange Commission on February 2, 2005

Registration No. 333-_____


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

PHARMION CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction
of incorporation or organization)
  84-1521333
(I.R.S. Employer
Identification Number)

2525 28th Street
Boulder, Colorado 80301
(Address of principal executive offices)


Pharmion Corporation 2000 Stock Incentive Plan
Pharmion Corporation 2001 Non-Employee Director Stock Option Plan

(Full title of the plans)

Patrick J. Mahaffy
President and Chief Executive Officer
Pharmion Corporation
2525 28th Street
Boulder, Colorado 80301
(720) 564-9100
(Name, address and telephone number, including area code, of agent for service)


Copies to
Peter H. Jakes, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019
(212) 728-8000


CALCULATION OF REGISTRATION FEE

                                             
 
Title of securities to be registered
    Amount to be
registered (1)
    Proposed maximum
offering price per
share
    Proposed maximum
aggregate offering
price
    Amount of
registration fee
 
 
Common Stock, par value $0.001 per share
      4,000       $ 35.99(2)       $ 143,960       $ 17  
 
Common Stock, par value $0.001 per share
      456,296       $ 35.92(3)       $ 16,390,152       $ 1,930  
 
Common Stock, par value $0.001 per share
      18,854       $ 42.34(2)       $ 798,279       $ 94  
 
Common Stock, par value $0.001 per share
      1,850       $ 43.09(2)       $ 79,717       $ 10  
 
Common Stock, par value $0.001 per share
      250       $ 42.21(2)       $ 10,553       $ 2  
 
Common Stock, par value $0.001 per share
      250       $ 44.61(2)       $ 11,153       $ 2  
 
Common Stock, par value $0.001 per share
      51,500       $ 41.63(2)       $ 2,143,945       $ 253  
 
Common Stock, par value $0.001 per share
      15,000       $ 38.00(2)       $ 570,000       $ 68  
 
Common Stock, par value $0.001 per share
      2,000       $ 36.83(2)       $ 73,660       $ 9  
 
Total:
      550,000                           $ 2,385(4)    
 

     (1) This Registration Statement covers 500,000 shares of the common stock of Pharmion Corporation, $0.001 par value per share (the “Common Stock”), issuable pursuant to the Pharmion Corporation 2000 Stock Incentive Plan and 50,000 shares of Common Stock issuable pursuant to the Pharmion Corporation 2001 Non-Employee Director Stock Option Plan (collectively, the “Plans”). In addition, this Registration Statement covers an indeterminable number of additional shares of Common Stock as may hereafter be offered or issued pursuant to the Plans, to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without receipt of consideration and pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”).

     (2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Securities Act based upon the price at which the option may be exercised.

     (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Securities Act based on the average of the high and low reported sales price per share of our common stock on January 26, 2005, as reported on the Nasdaq National Market.

     (4) Pursuant to Rule 429(a) of the rules and regulations under the Securities Act, the prospectus prepared pursuant to Part I of Form S-8 also relates to the 3,133,000 shares of Common Stock included in the Registration Statement on Form S-8 (File No. 333-111158) relating to the Plans. The amount of the filing fee previously paid in connection with the registration of such shares of Common Stock was $3,576.32, based on the then applicable filing fees.



 


TABLE OF CONTENTS

PART II
Item 8. EXHIBITS
SIGNATURES
INDEX TO EXHIBITS
OPINION OF WILKIE FARR & GALLAGHER LLP.
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Table of Contents

Explanatory Note

          This Registration Statement on Form S-8, which incorporates by reference the Registrant’s previous Registration Statement on Form S-8 (File No. 333-111158), is being filed by the Registrant solely to register additional securities issuable pursuant to its 2000 Stock Incentive Plan and 2001 Non-Employee Director Stock Option Plan. Accordingly, this Registration Statement consists only of those items required by General Instruction E to Form S-8.

 


Table of Contents

PART II

INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT

Item 8. EXHIBITS

     Exhibit No.

     
5
  Opinion of Willkie Farr & Gallagher LLP with respect to the legality of the securities to be issued pursuant to the Plans.
 
   
23.1
  Consent of Independent Registered Public Accounting Firm.
 
   
23.2
  Consent of Willkie Farr & Gallagher LLP (contained in Exhibit 5).
 
   
24
  Power of Attorney (reference is made to the signature page hereto).

 


Table of Contents

SIGNATURES

                         Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boulder, Colorado, on the 31st day of January, 2005.

         
  Pharmion Corporation
 
 
  By:      /s/ Patrick J. Mahaffy    
  Name:    Patrick J. Mahaffy  
  Title:    President and Chief Executive Officer   
 

               Each of the undersigned officers and directors of Pharmion Corporation hereby severally constitutes and appoints Patrick J. Mahaffy and Erle T. Mast, and each of them, as the attorneys-in-fact for the undersigned, in any and all capacities, with full power of substitution, to sign any and all amendments (including post-effective amendments, exhibits thereto and other documents in connection therewith) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, and each of them, may lawfully do or cause to be done by virtue hereof.

               Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

         
Signature   Title   Date
 
    /s/ Patrick J. Mahaffy
Patrick J. Mahaffy
  President and Chief
Executive Officer;
Director (Principal
Executive Officer)
  January 31, 2005
 
       
   /s/ Judith A. Hemberger
Judith A. Hemberger
  Executive Vice
President and Chief
Operating Officer;
Director
  January 31, 2005
 
       
   /s/ Erle T. Mast
Erle T. Mast
  Chief Financial Officer
(Principal Financial
Officer and Principal
Accounting Officer)
  January 31, 2005
 
       
   /s/ Brian Atwood
Brian Atwood
  Director   January 31, 2005

 


Table of Contents

         
Signature   Title   Date
 
       
   /s/ James Blair
James Blair
  Director   January 31, 2005
 
       
   /s/ James Barrett
James Barrett
  Director   January 31, 2005
 
       
   /s/ Cam L. Garner
Cam L. Garner
  Director   January 31, 2005
 
       
   /s/ Edward J. McKinley
Edward J. McKinley
  Director   January 31, 2005
 
       
   /s/ Thorlef Spickschen
Thorlef Spickschen
  Director   January 31, 2005

 


Table of Contents

INDEX TO EXHIBITS

         
Exhibit No.   Description of Exhibit
 
5
  Opinion of Willkie Farr & Gallagher LLP.
 
 
   
 
23.1
  Consent of Independent Registered Public Accounting Firm.
 
 
   
 
23.2
  Consent of Willkie Farr & Gallagher LLP (contained in Exhibit 5).
 
 
   
 
24
  Power of Attorney (reference is made to the signature page hereto).